1. Home
  2. NTCT vs NVAX Comparison

NTCT vs NVAX Comparison

Compare NTCT & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTCT
  • NVAX
  • Stock Information
  • Founded
  • NTCT 1984
  • NVAX 1987
  • Country
  • NTCT United States
  • NVAX United States
  • Employees
  • NTCT N/A
  • NVAX N/A
  • Industry
  • NTCT EDP Services
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NTCT Technology
  • NVAX Health Care
  • Exchange
  • NTCT Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • NTCT 1.6B
  • NVAX 1.3B
  • IPO Year
  • NTCT 1999
  • NVAX 1995
  • Fundamental
  • Price
  • NTCT $22.41
  • NVAX $9.58
  • Analyst Decision
  • NTCT Hold
  • NVAX Buy
  • Analyst Count
  • NTCT 1
  • NVAX 6
  • Target Price
  • NTCT $25.00
  • NVAX $15.33
  • AVG Volume (30 Days)
  • NTCT 676.1K
  • NVAX 8.0M
  • Earning Date
  • NTCT 08-07-2025
  • NVAX 08-06-2025
  • Dividend Yield
  • NTCT N/A
  • NVAX N/A
  • EPS Growth
  • NTCT N/A
  • NVAX N/A
  • EPS
  • NTCT 1.02
  • NVAX 2.54
  • Revenue
  • NTCT $834,861,000.00
  • NVAX $1,078,718,000.00
  • Revenue This Year
  • NTCT $3.89
  • NVAX $52.02
  • Revenue Next Year
  • NTCT $2.40
  • NVAX N/A
  • P/E Ratio
  • NTCT $22.08
  • NVAX $3.76
  • Revenue Growth
  • NTCT 5.29
  • NVAX 9.22
  • 52 Week Low
  • NTCT $18.12
  • NVAX $5.01
  • 52 Week High
  • NTCT $27.89
  • NVAX $15.22
  • Technical
  • Relative Strength Index (RSI)
  • NTCT 50.81
  • NVAX 72.18
  • Support Level
  • NTCT $22.21
  • NVAX $7.76
  • Resistance Level
  • NTCT $23.20
  • NVAX $9.13
  • Average True Range (ATR)
  • NTCT 0.66
  • NVAX 0.59
  • MACD
  • NTCT 0.18
  • NVAX 0.24
  • Stochastic Oscillator
  • NTCT 71.89
  • NVAX 91.22

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: